The Members were reminded to follow up on their commitment
enable the signature of APAs with vaccine providers/manufacturers.
The Members discussed various aspects on the logistic, which can be relevant in a strategic
discussion on the
vaccines.
The Members were informed that at the next meeting AstraZeneca would provide an update on
Clinical trials, manufacturing and approval.
The Commission provided a short update on the state of play regarding the
Joint procurement
for the supply of medical equipment for COVID-19 vaccination, for which the evaluation of
the tender evaluation was ongoing.
The Commission anticipates the evaluation to be finalized by
(largely depending
on the quality of offers and reactivity of companies), while the orders could be placed as of
ensuring that supplies are available in time for national deployment of COVID-19
vaccines.
The Commission also asked the MSs to inform if they launched or signed national procurement
on syringes and needles in parallel, information that could be relevant for adjusting the offer to
the needs of the Member States.
Note post meeting: The update should be send to:
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx
O
The Committee informed that the Joint Procurement Steering Committee would meet
and update on the joint procurement of syringes and needles.